Prescription medicine
Manganese chloride
Manganese chloride is a prescription medicine with an FDA approval on record since 1986. FDA's NDC Directory lists it from 1 generic labeler.
- Generic listed
Check it at the source: the manganese chloride FDA label on DailyMed (effective April 15, 2026, Hospira, Inc.); the NDA 18962 record on Drugs@FDA; every manganese chloride label on DailyMed.
Highlights of the record
FDA label of April 15, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageManganese 0.1 mg/mL (Manganese Chloride Injection, USP) is indicated for use in adult patients as a supplement to intravenous solutions given for TPN.
Forms and strengths
- 0.1 mg/ml
Injection (solution).
On the market
- Earliest approval on file
- June 26, 1986 Manganese Chloride In Plastic Container, Hospira; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 1 first July 7, 2025; 1 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 2 of which 1 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 274 through July 30, 2026
What is manganese chloride used for?
From the label: indications and usageManganese 0.1 mg/mL (Manganese Chloride Injection, USP) is indicated for use in adult patients as a supplement to intravenous solutions given for TPN. Administration helps to maintain manganese serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
FDA pharmacologic class: Paramagnetic Contrast Agent.
Source: FDA drug label (MANGANESE), Hospira, Inc., effective April 15, 2026 (SPL set 6e979070-5035-4076-e09c-b52466be3c68), via openFDA; the full label on DailyMed
Is there a generic for manganese chloride?
The FDA approved the first generic manganese chloride on July 7, 2025. 1 generic application is approved; 1 of it carries a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists manganese chloride from 1 labeler under a generic (ANDA) application and from 1 brand labeler. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1986 earliest approval on file
- 2025 first generic approved
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do FAERS reports show for manganese chloride?
The FDA Adverse Event Reporting System holds 274 reports that list manganese chloride among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 10 are coded as a death and 74 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other paramagnetic contrast agents
- the pharmacologic class, with prices and generics
- Manganese chloride side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other